CN Patent

CN105727297A — 包含hsp90抑制剂和mtor抑制剂的药物组合

Assigned to Novartis AG · Expires 2016-07-06 · 10y expired

What this patent protects

本发明涉及包含HSP90抑制剂和MTOR抑制剂的药物组合。具体而言，本发明涉及包含Hsp90抑制剂和mTOR抑制剂的药物组合产品，以及使用所述组合产品来治疗或预防增殖性疾病的方法。

USPTO Abstract

本发明涉及包含HSP90抑制剂和MTOR抑制剂的药物组合。具体而言，本发明涉及包含Hsp90抑制剂和mTOR抑制剂的药物组合产品，以及使用所述组合产品来治疗或预防增殖性疾病的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105727297A
Jurisdiction
CN
Classification
—
Expires
2016-07-06
Drug substance claim
No
Drug product claim
No
Assignee
Novartis AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.